Stock detail
Incyte (INCY) stock price, chart, and key data
View Incyte stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Incyte
INCY · XNAS
$116.80
0.00%
$0.00
Pre-market $118.12 (+1.13%)
Key metrics
52-week range
$10.25 - $20.00
Close price
$116.80
Market cap
$23.7B
P/E ratio
41.57
Beta
1.64
About the company
Incyte Genomics Inc
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia. Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity.
Analyst rating summary
A current read on analyst sentiment from the insight feed.
Mean target
$134
10
Buy
/ 18
Recent calls
10/28/2026
Barclays
Etzer Darout
Buy · Price target $139
10/27/2026
RBC Capital
Brian Abrahams
Hold · Price target $114
10/27/2026
Truist Financial
Srikripa Devarakonda
Hold · Price target $115
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app